면역글로불린 시장 규모, 점유율, 성장 분석 : 제품 유형별, 형태별, 투여 방법별, 용도별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Immunoglobulin Market size was valued at USD 16.08 Billion in 2024 and is poised to grow from USD 17.19 Billion in 2025 to USD 29.31 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global Immunoglobulin market is witnessing substantial growth, primarily fueled by the rising incidence of immunological disorders, advancements in diagnostic and therapeutic approaches, a supportive regulatory framework, and increasing healthcare spending. Innovations and a commitment to research and development are improving the effectiveness and quality of Immunoglobulin therapies. Additionally, emerging markets, especially in the Asia-Pacific and Latin America regions, offer significant opportunities for market expansion. These insights highlight a favorable growth outlook for the global Immunoglobulin market, encouraging industry stakeholders to prioritize innovation, enhance production capabilities, and implement effective market penetration strategies to satisfy the escalating demand for Immunoglobulin therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoglobulin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoglobulin Market Segments Analysis

Global Immunoglobulin Market is segmented by Product Type, Form, Mode of Delivery, Application, Distribution Channel and region. Based on Product Type, the market is segmented into IgG, IgA, IgM, IgE and IgD. Based on Form, the market is segmented into Liquid and Lyophilized. Based on Mode of Delivery, the market is segmented into Intravenous, Subcutaneous and Intramuscular. Based on Application, the market is segmented into Primary Immunodeficiency Disease, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura (ITP), Guillain-Barre Syndrome and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drug Stores & Retail Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunoglobulin Market

A significant factor driving the global Immunoglobulin market is the rising occurrence of immunological disorders, which necessitate effective treatments. Immunoglobulins play a vital role in managing various conditions such as primary immunodeficiencies, autoimmune diseases, and infections. The heightened awareness and improved diagnostic techniques have led to increased demand for Immunoglobulin therapies. Contributing factors include genetic predispositions, environmental influences, and changes in lifestyle that elevate the incidence of these disorders worldwide. Furthermore, enhancements in healthcare infrastructure and greater accessibility to medical services, along with growing healthcare spending, bolster the expansion of the Immunoglobulin market.

Restraints in the Global Immunoglobulin Market

A primary limitation facing the global Immunoglobulin market is the elevated cost associated with Immunoglobulin therapies. The intricate processes involved in the production, purification, and storage of these therapies necessitate advanced and costly manufacturing techniques, which drive up production expenses. Consequently, this impacts the pricing of Immunoglobulin products, rendering them prohibitively expensive for both patients and healthcare systems, especially in developing regions with constrained healthcare funding. Additionally, reimbursement challenges and restrictions in insurance coverage further exacerbate the financial burden on patients. To effectively overcome this obstacle, it is crucial to focus on strategies that lower manufacturing costs, enhance market competition, and improve access to affordable Immunoglobulin therapies.

Market Trends of the Global Immunoglobulin Market

The global Immunoglobulin market is witnessing a significant trend characterized by the rising demand for intravenous immunoglobulin (IVIG) therapy. This therapeutic approach, which delivers Immunoglobulin intravenously, is gaining traction among patients suffering from immunodeficiency disorders, autoimmune diseases, and neurological conditions, primarily due to its proven efficacy. Heightened awareness among healthcare professionals and patients regarding the therapeutic benefits of IVIG is further propelling its adoption. Additionally, advancements in production processes, enhanced product safety profiles, and a broader range of approved indications stimulate market growth. Coupled with an increasing prevalence of immunological disorders and an aging population, these factors significantly bolster the demand for Immunoglobulin products and IVIG therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Technology Analysis
• Patent Analysis
• Clinical Trial Analysis
• Pipeline Analysis
• Case Studies

Global Immunoglobulin Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• IgG
• IgA
• IgM
• IgE
• IgD

Global Immunoglobulin Market Size by Form & CAGR (2026-2033)

• Market Overview
• Liquid
• Lyophilized

Global Immunoglobulin Market Size by Mode of Delivery & CAGR (2026-2033)

• Market Overview
• Intravenous
  • 5% concentration
  • 10% concentration
  • Others
• Subcutaneous
  • 16.5% concentration
  • 20% concentration
  • Others
• Intramuscular

Global Immunoglobulin Market Size by Application & CAGR (2026-2033)

• Market Overview
• Primary Immunodeficiency Disease
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Idiopathic Thrombocytopenic Purpura (ITP)
• Guillain-Barre Syndrome
• Others

Global Immunoglobulin Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Drug Stores & Retail Pharmacy
• Others

Global Immunoglobulin Market Size & CAGR (2026-2033)

• North America (Product Type, Form, Mode of Delivery, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Form, Mode of Delivery, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Form, Mode of Delivery, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Form, Mode of Delivery, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Form, Mode of Delivery, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (BPL) Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADMA Biologics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma Ltd.(Bharat Serums and Vaccines Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Green Cross Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Blood Products Organization (JBPO)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Grand Enterprises, Inc (Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kamada Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prothya Biosolutions B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations